Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
0.7092
+0.0093 (1.33%)
At close: May 9, 2025, 4:00 PM
0.7219
+0.0127 (1.79%)
After-hours: May 9, 2025, 6:58 PM EDT

Ironwood Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
108.4888.5692.15656.2620.13362.56
Upgrade
Cash & Short-Term Investments
108.4888.5692.15656.2620.13362.56
Upgrade
Cash Growth
-10.75%-3.90%-85.96%5.82%71.04%104.81%
Upgrade
Accounts Receivable
39.7781.89129.12115.46114.04122.35
Upgrade
Receivables
39.7781.89129.12115.46114.04122.35
Upgrade
Prepaid Expenses
12.3311.9212.017.728.699.19
Upgrade
Restricted Cash
---1.251.251.74
Upgrade
Other Current Assets
----1.12-
Upgrade
Total Current Assets
160.58182.37233.29780.63745.23495.84
Upgrade
Property, Plant & Equipment
14.8815.5218.1720.3122.9325.51
Upgrade
Other Intangible Assets
2.662.863.68---
Upgrade
Long-Term Deferred Tax Assets
143.56144.23212.32283.66333.29-
Upgrade
Long-Term Deferred Charges
-3.92.4---
Upgrade
Other Long-Term Assets
5.542.021.2115.9225.4837.89
Upgrade
Total Assets
327.21350.91471.071,1011,127559.24
Upgrade
Accounts Payable
5.832.137.830.480.940.66
Upgrade
Accrued Expenses
39.072647.2217.7133.2915.77
Upgrade
Current Portion of Long-Term Debt
--199.56-116.86-
Upgrade
Current Portion of Leases
3.23.193.133.073.133.13
Upgrade
Current Income Taxes Payable
-0.521.240.66--
Upgrade
Current Unearned Revenue
-2.032.62---
Upgrade
Other Current Liabilities
-4.9814.53.617.4912.61
Upgrade
Total Current Liabilities
48.138.85276.125.53161.732.17
Upgrade
Long-Term Debt
584.16583.99498.31396.25337.33430.26
Upgrade
Long-Term Leases
11.7212.314.5416.618.4820.32
Upgrade
Long-Term Unearned Revenue
-1.8----
Upgrade
Other Long-Term Liabilities
17.2915.3128.429.773.513.85
Upgrade
Total Liabilities
661.27652.24817.37448.14521.02496.6
Upgrade
Common Stock
-334.050.160.160.150.160.16
Upgrade
Additional Paid-In Capital
-1,3951,3551,3491,5431,529
Upgrade
Retained Earnings
--1,698-1,699-696.38-937.61-1,466
Upgrade
Comprehensive Income & Other
-0.92-3.03---
Upgrade
Shareholders' Equity
-334.05-301.34-346.3652.38605.9162.64
Upgrade
Total Liabilities & Equity
327.21350.91471.071,1011,127559.24
Upgrade
Total Debt
599.08599.48715.54415.92475.8453.7
Upgrade
Net Cash (Debt)
-490.6-510.92-623.38240.29144.33-91.14
Upgrade
Net Cash Growth
---66.49%--
Upgrade
Net Cash Per Share
-3.07-3.19-4.011.290.88-0.57
Upgrade
Filing Date Shares Outstanding
160.97161.81156.53154.16159.22160.96
Upgrade
Total Common Shares Outstanding
160.97160.21156.35154.03162.04160.62
Upgrade
Working Capital
112.48143.52-42.81755.1583.53463.67
Upgrade
Book Value Per Share
-2.08-1.88-2.214.243.740.39
Upgrade
Tangible Book Value
-336.71-304.2-349.98652.38605.9162.64
Upgrade
Tangible Book Value Per Share
-2.09-1.90-2.244.243.740.39
Upgrade
Machinery
-3.895.424.234.134.71
Upgrade
Leasehold Improvements
-7.417.417.417.417.41
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q